Galapagos NV
A biotechnology company focused on a rapid, decentralized cell therapy platform.
GLPG | BR
Overview
Corporate Details
- ISIN(s):
- BE0003818359
- LEI:
- 549300QKJ78IY0IOV655
- Country:
- Belgium
- Address:
- Industriepark Mechelen Noord, Generaal De Wittelaan L11 A3, 2800 Mechelen
- Website:
- https://www.glpg.com/
- Sector:
- Manufacturing
Description
Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-26 07:30 |
Galapagos ontvangt transparantieverklaringen van Bank of America .pdf
|
Dutch | PDF • 283.4 KB | ||
| 2025-11-06 06:29 |
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Upda…
|
English | PDF • 465.4 KB | ||
| 2025-11-06 06:29 |
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Upda…
|
Dutch | PDF • 593.4 KB | ||
| 2025-11-05 22:01 |
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Upda…
|
English | PDF • 465.4 KB | ||
| 2025-11-05 22:01 |
Galapagos rapporteert financiële resultaten over de eerste negen maanden van 20…
|
Dutch | PDF • 593.4 KB | ||
| 2025-11-04 07:51 |
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
|
Dutch | PDF • 302.8 KB | ||
| 2025-11-04 07:51 |
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
|
English | PDF • 291.0 KB | ||
| 2025-10-31 07:43 |
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Busin…
|
Dutch | PDF • 269.7 KB | ||
| 2025-10-31 07:43 |
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Busin…
|
English | PDF • 252.8 KB | ||
| 2025-10-24 08:02 |
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Different…
|
English | PDF • 274.4 KB | ||
| 2025-10-24 08:02 |
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Different…
|
Dutch | PDF • 317.7 KB | ||
| 2025-10-21 08:24 |
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the…
|
Dutch | PDF • 288.2 KB | ||
| 2025-10-21 08:24 |
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the…
|
English | PDF • 274.0 KB | ||
| 2025-10-21 07:30 |
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the…
|
English | PDF • 274.0 KB | ||
| 2025-10-21 07:30 |
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onde…
|
Dutch | PDF • 288.2 KB |
Automate Your Workflow. Get a real-time feed of all Galapagos NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Galapagos NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Galapagos NV via our API.
Peer Companies
